Ma G, Gao Y, Jing X, He C, et al. Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma. Leuk Lymphoma 2022 Oct 10:1-11. doi: 10.1080/10428194.2022.2131427.
PMID: 36215154